Table: RaQualia Pharma -2019 group results

RaQualia Pharma

14/02/2020 06:15

Feb 14 (Reuters)- 
          RaQualia Pharma Inc 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Dec 31, 2019    Dec 31, 2018   Dec 31, 2020     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales             1.70           744 mln         2.13                  
                (+128.7 pct)     (-47.5 pct)    (+25.0 pct)              
  Operating      loss 15 mln      loss 1.08       70 mln                 
  Recurring        21 mln         loss 1.06       85 mln                 
                                               (+296.4 pct)              
  Net
  Net               5 mln         loss 1.10       13 mln                 
                                               (+161.6 pct)              
  EPS             0.26 yen     loss 54.23 yen    0.67 yen                
  EPS Diluted     0.26 yen                                               
  Ann Div            NIL             NIL            NIL                  
  -Q2 Div            NIL             NIL            NIL                  
  -Q4 Div            NIL             NIL            NIL                  
  
  NOTE - RaQualia Pharma Inc.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T